论文部分内容阅读
目的探讨溴化钠苯甲酸钠咖啡因合剂联合帕罗西丁对脑卒中后抑郁患者的临床疗效。方法将196例脑卒中后抑郁患者随机分为两组,均针对原发病进行常规治疗及浅层心理治疗,治疗组予溴化钠苯甲酸钠咖啡因合剂联合帕罗西丁治疗,对照组单用帕罗西丁治疗。8周为1个疗程。结果分别采用汉密尔顿抑郁量表、神经功能缺损程度比较差异有统计学意义(P<0.05),治疗组优于对照组。结论溴化钠苯甲酸钠咖啡因合剂联合帕罗西丁能明显改善脑卒中后抑郁患者的抑郁状态,促进神经功能恢复。
Objective To investigate the clinical efficacy of sodium bromide, sodium benzoate and caffeine combined with paroxetine in patients with post-stroke depression. Methods A total of 196 patients with post-stroke depression were randomly divided into two groups. All the patients were treated with conventional therapy and shallow psychotherapy. The patients in the treatment group received sodium caffeoate caffeine combined with paroxetine, while those in the control group Paroxetine treatment. 8 weeks for a course of treatment. The results were Hamilton Depression Scale, the degree of neurological deficit was statistically significant difference (P <0.05), the treatment group was better than the control group. Conclusion Sodium bromide, sodium benzoate and caffeine combined with paroxetine can significantly improve the depression status of post-stroke depression patients and promote the recovery of neurological function.